Gotowe bibliografie tematyczne / Presentation of peptides

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Presentation of peptides”

Autor: Grafiati
Data publikacji: 30 listopada 2024
Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Presentation of peptides”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Presentation of peptides"

1

Wen, R., G. A. Cole, S. Surman, M. A. Blackman, and D. L. Woodland. "Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells." Journal of Experimental Medicine 183, no. 3 (1996): 1083–92. http://dx.doi.org/10.1084/jem.183.3.1083.

Pełny tekst źródła
Streszczenie:
Recent studies have shown that only a subset of major histocompatibility complex (MHC) class II molecules are able to present bacterial superantigens to T cells, leading to the suggestion that class-II associated peptides may influence superantigen presentation. Here, we have assessed the potential role of peptides on superantigen presentation by (a) analyzing the ability of superantigens to block peptide-specific T cell responses and (b) analyzing the ability of individual peptides to promote superantigen presentation on I-Ab-expressing T2 cells that have a quantitative defect in antigen proc
Style APA, Harvard, Vancouver, ISO itp.
2

Utz, U., S. Koenig, J. E. Coligan, and W. E. Biddison. "Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule." Journal of Immunology 149, no. 1 (1992): 214–21. http://dx.doi.org/10.4049/jimmunol.149.1.214.

Pełny tekst źródła
Streszczenie:
Abstract To determine whether similar or dissimilar molecular features of class I molecules are involved in the presentation of structurally distinct peptides, we have investigated the influence of different pockets of the HLA-A2.1 molecule on the presentation of three different viral peptides. HTLV-I Tax peptide 12-19, HCMV gB 619-628, and influenza M1 58-66 are minimal peptides that induce HLA-A2.1-restricted noncross-reactive CTL. A detailed analysis of the structural features of HLA-A2.1 that are involved in peptide presentation was undertaken using a panel of 11 HLA-A2 mutants with single
Style APA, Harvard, Vancouver, ISO itp.
3

Zandvliet, Maarten L., J. H. Frederik Falkenburg, Michel G. D. Kester, et al. "Sequence Dependent Efficiency of Cross-Presentation in MHC Class I Requires Rational Design of Long Synthetic Peptides for Vaccination or Ex Vivo Activation." Blood 112, no. 11 (2008): 3904. http://dx.doi.org/10.1182/blood.v112.11.3904.3904.

Pełny tekst źródła
Streszczenie:
Abstract For the induction or boosting of antigen-specific CD8+ T cell responses, long synthetic peptides have been used in vaccination studies. Superior in vivo CD8+ T cell responses have been reported following vaccination with long peptides compared with minimal peptides, which was attributed to selective uptake and cross-presentation by professional antigen-presenting cells. Furthermore, to generate antigen-specific T cell lines for adoptive immunotherapy or to measure antigen-specific T cell responses, protein-spanning pools of overlapping long synthetic peptides can be used to simultaneo
Style APA, Harvard, Vancouver, ISO itp.
4

Neisig, A., J. Roelse, A. J. Sijts, et al. "Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences." Journal of Immunology 154, no. 3 (1995): 1273–79. http://dx.doi.org/10.4049/jimmunol.154.3.1273.

Pełny tekst źródła
Streszczenie:
Abstract The MHC-encoded transporter associated with Ag presentation (TAP) translocates peptides from the cytosol to the ER lumen, where association with MHC class I molecules occurs. The MHC class I/peptide complex is subsequently transported to the cell surface for presentation to CD8+T cells. We studied TAP-dependent translocation of defined MHC class I presentable murine peptides by competition for translocation of a radiolabeled model peptide, to address whether efficient peptide presentation by MHC class I molecules is preceded by equal efficient peptide translocation by TAP. Surprisingl
Style APA, Harvard, Vancouver, ISO itp.
5

Fremont, Daved H., Shaodong Dai, Herbert Chiang, Frances Crawford, Philippa Marrack, and John Kappler. "Structural Basis of Cytochrome c Presentation by IEk." Journal of Experimental Medicine 195, no. 8 (2002): 1043–52. http://dx.doi.org/10.1084/jem.20011971.

Pełny tekst źródła
Streszczenie:
The COOH-terminal peptides of pigeon and moth cytochrome c, bound to mouse IEk, are two of the most thoroughly studied T cell antigens. We have solved the crystal structures of the moth peptide and a weak agonist–antagonist variant of the pigeon peptide bound to IEk. The moth peptide and all other peptides whose structures have been solved bound to IEk, have a lysine filling the p9 pocket of IEk. However, the pigeon peptide has an alanine at p9 shifting the lysine to p10. Rather than kinking to place the lysine in the anchor pocket, the pigeon peptide takes the extended course through the bind
Style APA, Harvard, Vancouver, ISO itp.
6

Hombach, J., H. Pircher, S. Tonegawa, and R. M. Zinkernagel. "Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein." Journal of Experimental Medicine 182, no. 5 (1995): 1615–19. http://dx.doi.org/10.1084/jem.182.5.1615.

Pełny tekst źródła
Streszczenie:
Peptides presented by major histocompatibility complex (MHC) class I molecules are derived from intracellularly synthesized proteins. Cytosolic proteins are fragmented into peptides, which are subsequently transported via the transporter of antigen presentation (TAP) into the endoplasmic reticulum (ER), where they bind to MHC class I molecules. We have investigated the requirements for MHC class I presentation of the immunodominant gp33 cytotoxic T lymphocyte epitope of the lymphocytic choriomeningitis virus. This epitope is located within the leader peptide of the virus glycoprotein. Such an
Style APA, Harvard, Vancouver, ISO itp.
7

Daniel, Soizic, Vladimir Brusic, Sophie Caillat-Zucman, et al. "Relationship Between Peptide Selectivities of Human Transporters Associated with Antigen Processing and HLA Class I Molecules." Journal of Immunology 161, no. 2 (1998): 617–24. http://dx.doi.org/10.4049/jimmunol.161.2.617.

Pełny tekst źródła
Streszczenie:
Abstract Efficiency of presentation of a peptide epitope by a MHC class I molecule depends on two parameters: its binding to the MHC molecule and its generation by intracellular Ag processing. In contrast to the former parameter, the mechanisms underlying peptide selection in Ag processing are poorly understood. Peptide translocation by the TAP transporter is required for presentation of most epitopes and may modulate peptide supply to MHC class I molecules. To study the role of human TAP for peptide presentation by individual HLA class I molecules, we generated artificial neural networks capa
Style APA, Harvard, Vancouver, ISO itp.
8

Mo, X. Y., Paolo Cascio, Kristen Lemerise, Alfred L. Goldberg, and Kenneth Rock. "Distinct Proteolytic Processes Generate the C and N Termini of MHC Class I-Binding Peptides." Journal of Immunology 163, no. 11 (1999): 5851–59. http://dx.doi.org/10.4049/jimmunol.163.11.5851.

Pełny tekst źródła
Streszczenie:
Abstract Most of the MHC class I peptides presented to the immune system are generated during the course of protein breakdown by the proteasome. However, the precise role of the proteasome, e.g., whether this particle or some other protease generates the carboxyl (C) and amino (N) termini of the presented 8- to 10-residue peptides, is not clear. Here, we show that presentation on Db of ASNENMETM, a peptide from influenza nucleoprotein, and on Kb of FAPGNYPAL, a peptide from Sendai virus nucleoprotein, was blocked by the proteasome inhibitor, lactacystin. Using plasmid minigene constructs encod
Style APA, Harvard, Vancouver, ISO itp.
9

Monji, T., and D. Pious. "Exogenously provided peptides fail to complex with intracellular class II molecules for presentation by antigen-presenting cells." Journal of Immunology 158, no. 7 (1997): 3155–64. http://dx.doi.org/10.4049/jimmunol.158.7.3155.

Pełny tekst źródła
Streszczenie:
Abstract Exogenously supplied antigenic peptides can bind to and be presented by cell surface class II molecules of APCs without prior processing. However, it has been unclear whether peptide Ags exogenously supplied to APCs can also form complexes with nascent intracellular class II molecules that contribute to Ag presentation. We found that exogenously provided peptide Ags, unlike whole protein Ags, are presented as efficiently by fixed as by unfixed B lymphoblastoid APCs, suggesting that intracellular processes do not contribute to the presentation of exogenously supplied peptides by unfixe
Style APA, Harvard, Vancouver, ISO itp.
10

Stryhn, A., L. O. Pedersen, T. Romme, et al. "pH dependence of MHC class I-restricted peptide presentation." Journal of Immunology 156, no. 11 (1996): 4191–97. http://dx.doi.org/10.4049/jimmunol.156.11.4191.

Pełny tekst źródła
Streszczenie:
Abstract The function of MHC class I molecules is to bind and present antigenic peptides to cytotoxic T cells. Here, we report that class I-restricted peptide presentation is strongly pH dependent. The presentation of some peptides was enhanced at acidic pH, whereas the presentation of others was inhibited. Biochemical peptide-MHC class I binding assays demonstrated that peptide-MHC class I complexes are more stable at neutral pH than at acidic pH. We suggest that acid-dependent peptide dissociation can generate empty class I molecules and that the resulting binding potential can be exploited
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Presentation of peptides"

1

Howarth, Mark. "The presentation of suboptimal peptides by MHC Class I." Thesis, University of Oxford, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.398092.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Springer, Sebastian Hartmut. "The biochemistry of antigen presentation." Thesis, University of Oxford, 1996. http://ora.ox.ac.uk/objects/uuid:34d1afd2-fafc-4732-8e43-e00dcd8460d1.

Pełny tekst źródła
Streszczenie:
This thesis describes studies on the binding of peptides to the murine major histocompatibility complex (MHC) class I molecule H-2D<sup>b</sup> (D<sup>b</sup>). The expression of the recombinant soluble D<sup>b</sup> molecule in Chinese hamster ovary cells and its subsequent purification by nickel affinity chromatography, gel filtration, and preparative native isoelectric focusing are reported. The product is the correct molecule, homogeneous, a dimer of dimers, and free of endogenous peptide. A novel binding assay based on the enhancement of natural tryptophan fluorescence by the binding of p
Style APA, Harvard, Vancouver, ISO itp.
3

Winchester, Christopher Charles. "The roles of Hsp70 proteins in antigen processing and presentation." Thesis, University of Oxford, 1997. http://ora.ox.ac.uk/objects/uuid:567dff45-08ce-43b4-b011-d08afea42f76.

Pełny tekst źródła
Streszczenie:
The ability of members of the hsp70 family to bind to peptides in vivo and in vitro suggests that they may be involved in the processing of antigens for binding to Major Histocompatibility (MHC) class I and/or class n molecules. The aims of this thesis have been to provide evidence for the involvement of hsp70s in antigen processing and to characterise the binding of peptides by hspTOs by structural and functional studies. Firstly, the peptide-binding domains of two hsp70s, hsp70hom and PBP74, were expressed in isolation from the rest of the molecule for structure determination. Both of these
Style APA, Harvard, Vancouver, ISO itp.
4

Farfán, Arribas Diego José. "On the Source of Peptides for Major Histocompatibility Class I Antigen Presentation: A Dissertation." eScholarship@UMMS, 2012. https://escholarship.umassmed.edu/gsbs_diss/589.

Pełny tekst źródła
Streszczenie:
Peptides generated from cellular protein degradation via the ubiquitin-proteasome pathway are presented on MHC class I as a means for the immune system to monitor polypeptides being synthesized by cells. For CD8 + T cells to prevent the spread of an incipient infection, it appears essential they should be able to sense foreign polypeptides being synthesized as soon as possible. A prompt detection of viral proteins is of great importance for the success of an adaptive immune response. Defective ribosomal products (DRiPs) have been postulated as a preferential source which would allow for a rapi
Style APA, Harvard, Vancouver, ISO itp.
5

Lenz, Laurel L. "Presentation of formylated bacterial peptides to cytotoxic T cells by an MHC class Ib molecule /." Thesis, Connect to this title online; UW restricted, 1998. http://hdl.handle.net/1773/8339.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Thomas, Lawrence James. "Proteolytic Cleavages of Molecules Involved in Antigen Processing and Presentation: A Thesis." eScholarship@UMMS, 1989. https://escholarship.umassmed.edu/gsbs_diss/97.

Pełny tekst źródła
Streszczenie:
The overall goal of my thesis research was to understand better the mechanisms that control antigen processing and presentation by class II MHC molecules. Towards this goal I investigated ways in which the physical structure and post-translational modifications of the class II MHC alpha and beta chains and associated molecules might serve to regulate antigen processing and presentation. Specifically, I investigated (1) a hypothesis that Ii might aid binding of foreign antigenic peptides to the class II MHC foreign antigen binding site (desetope), and the application of this hypothesis to the p
Style APA, Harvard, Vancouver, ISO itp.
7

Parshotam, L. E. "Dynamic modelling of the processing of peptides for presentation on major histocompatibility complex class I proteins." Thesis, University College London (University of London), 2017. http://discovery.ucl.ac.uk/1559176/.

Pełny tekst źródła
Streszczenie:
Antigen presentation is broadly implicated in disease and represents an important target for prophylactic and therapeutic treatments. A better understanding of the components of this system is fundamental to our understanding of disease path- ways and to treatment design. This thesis focuses on modelling the processing of peptides by enzymes in the cytosol and in the endoplasmic reticulum (ER) in the context of major histocompatibility complex class I (MHC) antigen presentation, and expounds upon current knowledge of the mechanistic details and specificity of both the proteasome and the endopl
Style APA, Harvard, Vancouver, ISO itp.
8

Eccleston, Ruth Charlotte. "A mechanistic model predicting cell surface presentation of peptides by MHC class I proteins, considering peptide competition, viral intracellular kinetics and host genotype factors." Thesis, University College London (University of London), 2017. http://discovery.ucl.ac.uk/10038760/.

Pełny tekst źródła
Streszczenie:
Major histocompatability complex class I (MHC-I) proteins present short fragments of pathogenic or cancerous proteins (peptides) on the surface of infected cells for recognition by T lymphocytes which are stimulated upon recognition of foreign peptides. Due to the diversity of peptide sequences and the sequence-specificity of MHC-I alleles, being able to determine which peptides will be presented by which MHC-I alleles and in what proportion could be important for the development of vaccines and treatments based on the presented peptiodome. Machine learning tools, trained on experimental data,
Style APA, Harvard, Vancouver, ISO itp.
9

McMurtrey, Curtis Paul. "Human leukocyte antigen class I presentation and immune recognition of West Nile virus peptide epitopes." Oklahoma City : [s.n.], 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Schirmacher, Anastasiya. "Modification of transmembrane peptides to probe SNARE-induced membrane fusion and cross-presentation of membrane-buried epitopes." Doctoral thesis, Niedersächsische Staats- und Universitätsbibliothek Göttingen, 2020. http://hdl.handle.net/21.11130/00-1735-0000-0005-1576-F.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Presentation of peptides"

1

Z, Atassi M., and Abbott Laboratories, eds. Immunobiology of proteins and peptides IV: T-cell recognition and antigen presentation. Plenum Press, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

F, Lüscher Thomas, ed. The endothelium in cardiovascular disease: Pathophysiology, clinical presentation, and pharmacotherapy. Springer, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Atassi, M. Zouhair, and Howard L. Bachrach. Immunobiology of Proteins and Peptides IV: T-Cell Recognition and Antigen Presentation. Springer London, Limited, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Atassi, M. Zouhair. Immunobiology of Proteins and Peptides Iv: T-Cell Recognition And Antigen Presentation. Springer, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Lüscher, Thomas F. Endothelium in Cardiovascular Disease: Pathophysiology, Clinical Presentation and Pharmacotherapy. Springer London, Limited, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Luscher, Thomas F. The Endothelium in Cardiovascular Disease: Pathophysiology, Clinical Presentation and Pharmacotherapy. Springer-Verlag Telos, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Luscher, Thomas F. The Endothelium in Cardiovascular Disease: Pathophysiology, Clinical Presentation, and Pharmacology. Springer-Verlag, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Levy, David. Presentation and early clinical course. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198766452.003.0002.

Pełny tekst źródła
Streszczenie:
The clinical importance of taking care with diagnostic terms for Type 1 diabetes and the need to avoid obsolete and confusing names. Clinical features at presentation of Type 1 diabetes, and features that differentiate it from later-onset autoimmune diabetes (LADA). The persistently high rate of presentation in diabetic ketoacidosis and its likely neuropsychiatric consequences. Key features of complex cases of DKA and current management strategies. The controversy over which subcutaneous insulin regimens to use after resolution of DKA. Definitions of and factors associated with partial remissi
Style APA, Harvard, Vancouver, ISO itp.
9

van der Vlag, Johan, and Jo H. M. Berden. The patient with systemic lupus erythematosus. Edited by Giuseppe Remuzzi. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0161.

Pełny tekst źródła
Streszczenie:
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with various clinical manifestations. The hallmark of SLE is the presence of antibodies against nuclear constituents, such as double-stranded (ds)DNA, histones, and nucleosomes. Local deposition of antinuclear antibodies in complex with nuclear autoantigens induces serious inflammatory conditions that can affect several tissues and organs, including the kidney.The levels of antinucleosome and anti-dsDNA antibodies seem to correlate with glomerulonephritis and these autoantibodies can often be detected years before the patient
Style APA, Harvard, Vancouver, ISO itp.

Części książek na temat "Presentation of peptides"

1

Wittmann, Valentin, and Sonja Seeberger. "Spatial Screening of Lectin Ligands. Cyclic Peptides as Scaffolds for Multivalent Presentation of Carbohydrates." In Peptides: The Wave of the Future. Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-010-0464-0_78.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Pierce, Susan K., Ellen K. Lakey, Emanuel Margoliash, Lori A. Smolenski, and Lisa A. Casten. "The Presentation of Processed, Ia Restricted, T Cell Antigenic Peptides on Antigen Presenting Cell Surfaces." In H-2 Antigens. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4757-0764-9_48.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Janeway, C. A., P. Preston-Hurlburt, B. Al-Ramadi, et al. "Rules for the Presentation of Peptides by Class II Molecules of the Major Histocompatibility Complex." In Progress in Immunology Vol. VIII. Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-51479-1_24.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Forquet, Frédérique, Ursula Danilczyk, Ying Lang, and Terry L. Delovitch. "Interactions between Peptides and Major Histocompatibility Complex Molecules during Antigen Processing and Presentation (Part 1 of 2)." In Chemical Immunology and Allergy. KARGER, 1993. http://dx.doi.org/10.1159/000319181.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Forquet, Frédérique, Ursula Danilczyk, Ying Lang, and Terry L. Delovitch. "Interactions between Peptides and Major Histocompatibility Complex Molecules during Antigen Processing and Presentation (Part 2 of 2)." In Chemical Immunology and Allergy. KARGER, 1993. http://dx.doi.org/10.1159/000319182.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Momburg, Frank, Günter J. Hämmerling, and Jacques J. Neefjes. "TAP Peptide Transporters and Antigen Presentation." In MHC Molecules: Expression, Assembly and Function. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4684-6462-7_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Haug, Markus, Günther E. Dannecker, and Ursula Holzer. "Impact of HSP-Chaperoned Peptides on the MHC Class II-Dependent Presentation and Activation of CD4+ T Cells in Regard of Allo- and Autoantigens." In Heat Shock Proteins: Potent Mediators of Inflammation and Immunity. Springer Netherlands, 2007. http://dx.doi.org/10.1007/978-1-4020-5585-0_17.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

van Bleek, Grada M., and Stanley G. Nathenson. "Peptide Presentation by Major Histocompatibility Class I Molecules." In Chemical Immunology and Allergy. KARGER, 1993. http://dx.doi.org/10.1159/000319173.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Jung, Günther. "Peptide presentation by major histocompatibility complex-class I and in vivo induction of cytotoxic T-lymphocytes." In Peptide Chemistry 1992. Springer Netherlands, 1993. http://dx.doi.org/10.1007/978-94-011-1474-5_180.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Compagnone, Mirco, and Doriana Fruci. "Peptide Trimming for MHC Class I Presentation by Endoplasmic Reticulum Aminopeptidases." In Antigen Processing. Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9450-2_4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Presentation of peptides"

1

Tian, Fei, Fan Yang, and Junfeng Liang. "Lab-on-fiber optofluidic platform for in-situ study of therapeutic peptides and bacterial response (Rising Researcher Presentation) (Conference Presentation)." In Smart Biomedical and Physiological Sensor Technology XIV, edited by Brian M. Cullum, Eric S. McLamore, and Douglas Kiehl. SPIE, 2017. http://dx.doi.org/10.1117/12.2262923.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Jiang, Yang, Jing Chen, Danielle K. Turgeon, Joel H. Rubenstein, Thomas D. Wang, and Eric J. Seibel. "Quantification of multiplexed fluorescence peptides in human esophagus for early cancer detection (Conference Presentation)." In Endoscopic Microscopy XIV, edited by Melissa J. Suter, Guillermo J. Tearney, and Thomas D. Wang. SPIE, 2019. http://dx.doi.org/10.1117/12.2511815.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Long, S. Randolph, and Chih-Cong Chou. "Laser Desorption/Ionization Mass Spectrometry of Biological Materials." In Laser Applications to Chemical Analysis. Optica Publishing Group, 1992. http://dx.doi.org/10.1364/laca.1992.pd5.

Pełny tekst źródła
Streszczenie:
The detection, identification, and analysis of biological materials in "real time" is of significant current interest in a number of fields. As with chemical materials, mass spectrometry holds great promise for such applications. We are presently engaged in a study of approaches to mass spectrometric analysis of biological materials, utilizing laser desorption/vaporization/ionization in conjunction with Fourier transform mass spectrometry. In this presentation, we focus on laser desorption/ionization applied to peptides. Although laser desorption can generate mass spectra with reasonably abund
Style APA, Harvard, Vancouver, ISO itp.
4

Taylor, Phillip. "Computational design of collagen-like-peptides (CLP) for desired CLP triple helix melting transition and assembled structure." In Proposed for presentation at the 2022 CINT Annual User Conference held September 20-22, 2022 in Albuquerque , NM. US DOE, 2022. http://dx.doi.org/10.2172/2004798.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Chan, Warren C. W. "Elucidating the Interactions of Nanomaterials With Biological Systems." In ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology. ASMEDC, 2010. http://dx.doi.org/10.1115/nemb2010-13377.

Pełny tekst źródła
Streszczenie:
Nanotechnology is a rapidly growing research fields with many applications in biology and medicine. At a heart of nanotechnology research is engineered nanostructures, which possess distinct optical, electronic, and magnetic properties based on their size, shape, and chemical composition. Researchers can now design their surface chemistry with small bi-functional organic molecules or amphiphillic polymers so that they are biocompatible and can be coated with bio-recognition molecules such as antibodies, aptamers, and peptides. Nanoparticles are used as a platform for drug delivery, as a physic
Style APA, Harvard, Vancouver, ISO itp.
6

Vicente, M. Graca H. "EGFR-targeted photosensitizer-peptide conjugates (Conference Presentation)." In 17th International Photodynamic Association World Congress, edited by Tayyaba Hasan. SPIE, 2019. http://dx.doi.org/10.1117/12.2528197.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Hochbaum, Allon. "Bioinspired design of conductive peptide nanofibers (Conference Presentation)." In Organic and Hybrid Sensors and Bioelectronics XI, edited by Ruth Shinar, Ioannis Kymissis, Luisa Torsi, and Emil J. List-Kratochvil. SPIE, 2018. http://dx.doi.org/10.1117/12.2322688.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Ashkenasy, Nurit. "Peptide based supramolecular materials for transient electronics (Conference Presentation)." In Organic and Hybrid Sensors and Bioelectronics XV, edited by Ruth Shinar, Ioannis Kymissis, and Emil J. List-Kratochvil. SPIE, 2022. http://dx.doi.org/10.1117/12.2633402.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Borum, Raina, Matthew N. Creyer, Yu-Ci Chang, and Jesse V. Jokerst. "Self-assembled peptide-dye nanoparticles for targeted photoacoustic tumor imaging (Conference Presentation)." In Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications XIV, edited by Ramesh Raghavachari and Mikhail Y. Berezin. SPIE, 2023. http://dx.doi.org/10.1117/12.2650751.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Zhang, Zhihong, Lisen Lu, Yuan Qian, Sha Qiao, and Qingming Luo. "Targeting delivery of nanovaccine/nanoimmunomudulator based on peptide-lipid nanoparticle for immunotherapy in vivo (Conference Presentation)." In Biophotonics and Immune Responses XIV, edited by Wei R. Chen. SPIE, 2019. http://dx.doi.org/10.1117/12.2507601.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Presentation of peptides"

1

Waqas, Muhammad Talha. Leveraging Machine Learning to Predict Peptide Presentation by MHC Proteins: A Comprehensive Research Analysis. ResearchHub Technologies, Inc., 2024. http://dx.doi.org/10.55277/researchhub.nic100aw.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Presentation of peptides” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii